Barinthus Biotherapeutics plc. financial data

Symbol
BRNS on Nasdaq
Location
Didcot, United Kingdom
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 827 % -18.2%
Debt-to-equity 25.1 % +48%
Return On Equity -70.1 % -105%
Return On Assets -56.1 % -91.4%
Operating Margin -454 % +95.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.8M shares +1.5%
Common Stock, Shares, Outstanding 40.8M shares +3.25%
Entity Public Float 31.1M USD -60.8%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 40.7M shares +3.15%
Weighted Average Number of Shares Outstanding, Diluted 40.7M shares +3.15%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 29.9M USD -25.7%
General and Administrative Expense 36.2M USD -9.91%
Operating Income (Loss) -82.4M USD -27.6%
Nonoperating Income (Expense) 6.32M USD +8.59%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -76.1M USD -29.5%
Income Tax Expense (Benefit) -115K USD +86.7%
Net Income (Loss) Attributable to Parent -75.9M USD -31.2%
Earnings Per Share, Basic -1 USD/shares -27%
Earnings Per Share, Diluted -1 USD/shares -27%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 74.3M USD
Accounts Receivable, after Allowance for Credit Loss, Current 172K USD -99%
Other Assets, Current 663K USD +42.9%
Assets, Current 86.8M USD -35.6%
Property, Plant and Equipment, Net 4.52M USD -57.8%
Operating Lease, Right-of-Use Asset 2.06M USD -72.3%
Intangible Assets, Net (Excluding Goodwill) 14.9M USD -34.4%
Goodwill 0 USD -100%
Assets 109M USD -42.1%
Accounts Payable, Current 698K USD -77.3%
Liabilities, Current 10.8M USD -28.4%
Deferred Income Tax Liabilities, Net 320K USD -30%
Operating Lease, Liability, Noncurrent 9.55M USD -10.6%
Other Liabilities, Noncurrent 1.46M USD +3.91%
Liabilities 24.6M USD -15.7%
Retained Earnings (Accumulated Deficit) -293M USD -34.9%
Stockholders' Equity Attributable to Parent 84.5M USD -47%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 84.6M USD -47%
Liabilities and Equity 109M USD -42.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.9M USD -26.1%
Net Cash Provided by (Used in) Financing Activities 2M USD +298%
Net Cash Provided by (Used in) Investing Activities -5K USD +98.4%
Common Stock, Shares Authorized 40.8M shares +3.25%
Common Stock, Shares, Issued 40.8M shares +3.25%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.8M USD +2.46%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 75.7M USD -28.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 30.8M USD +23%
Deferred Tax Assets, Gross 40.6M USD +12.2%
Operating Lease, Liability 11.6M USD -8.68%
Depreciation 3.1M USD +14.8%
Payments to Acquire Property, Plant, and Equipment 5K USD -98.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -76.2M USD -80.2%
Lessee, Operating Lease, Liability, to be Paid 14.8M USD -11.7%
Property, Plant and Equipment, Gross 16.8M USD +8.28%
Operating Lease, Liability, Current 2.02M USD +1.56%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.05M USD +1.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.02M USD +1.45%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -22K USD +40.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.24M USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.07M USD +1.47%
Deferred Tax Assets, Operating Loss Carryforwards 26M USD +10.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.1M USD +1.5%
Operating Lease, Payments 478K USD +38.2%
Additional Paid in Capital 393M USD +0.35%
Amortization of Intangible Assets 3.2M USD 0%
Depreciation, Depletion and Amortization 2.03M USD +42.2%
Deferred Tax Assets, Net of Valuation Allowance 9.81M USD -12.2%
Share-based Payment Arrangement, Expense 527K USD -88.9%
Interest Expense 12K USD